{
    "2018-03-16": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Pharma Stock Roundup: ABBV's Elagolix Meets Study Goal, MRK's Keytruda in Focus",
                "features": {
                    "keywords": [
                        "Pharma",
                        "ABBV",
                        "Elagolix",
                        "Study Goal",
                        "MRK",
                        "Keytruda"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Why Multiple Sclerosis is a Promising but Risky Space?",
                "features": {
                    "keywords": [
                        "Multiple Sclerosis",
                        "Promising",
                        "Risky"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Why A Biopharma Buying Spree May Target AstraZeneca, Bristol",
                "features": {
                    "keywords": [
                        "Biopharma",
                        "Buying Spree",
                        "AstraZeneca",
                        "Bristol"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharma Stock Roundup: ABBV's Elagolix Meets Study Goal, MRK's Keytruda in Focus",
                "features": {
                    "keywords": [
                        "Pharma",
                        "ABBV",
                        "Elagolix",
                        "Study Goal",
                        "MRK",
                        "Keytruda"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "5 Must-See Quotes From AbbVie's Management",
                "features": {
                    "keywords": [
                        "Quotes",
                        "AbbVie",
                        "Management"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "5 Must-See Quotes From AbbVie's Management",
                "features": {
                    "keywords": [
                        "Quotes",
                        "AbbVie",
                        "Management"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}